Born from a mission to upcycle 1 gigaton of CO2 by 2050, Phase Biolabs is turning the world’s most abundant waste gas into its most sustainable resource.
Backed by
Our story
Phase Biolabs was founded in 2020 with a mission that is as simple as it is ambitious: to upcycle 1 gigaton of CO2 by the year 2050. Born out of the Synthetic Biology Research Centre at the University of Nottingham, we have evolved from a breakthrough scientific concept into a leading industrial carbon-utilization platform.
Backed by Y Combinator and Bill Gates’ Breakthrough Energy, we leverage proprietary synthetic biology to transform one of the world’s biggest liabilities, industrial emissions, into one of its most valuable assets. By engineering microbes to outperform nature, we are not just capturing carbon; we are building the circular economy of the future, one retrofit at a time.
Why us
Our technology is built on years of research and development, offering a unique solution to the challenges of CO2 conversion. We differentiate ourselves with our ability to use CO2 directly, lower operational costs, and streamline your processes.
No need for complicated pre-processing steps.
Lower operational costs compared to traditional methods.
We’ve helped companies in various industries optimize their CO2 emissions and increase profitability.
Differentiators
Team
Core Strengths
Proven Technology
15+ years of gas fermentation R&D, and industrial scale across 3 countries.
Industrial Partnerships
Active partnerships with leading steel, cement, and energy groups across Europe.
Patent Portfolio
12+ patents protecting our microbial strains, bioreactor design, and downstream processes.
Retrofit-Friendly
Designed from the ground up to integrate with existing industrial infrastructure without full rebuilds.
